William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Xometry Announces Pricing of Initial Public Offering
-
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
-
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
-
Teknova Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Teknova Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
-
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
-
Grid Dynamics Holdings, Inc. (GDYN) Launches 10.1M Share Proposed Follow-on Offering
-
Grid Dynamics Launches Proposed Follow-on Offering
-
Sachem Capital Corp. Announces Closing of $42.5 Million Public Offering of Preferred Stock
-
TeamLogic IT Assists with Booming Cloud Essentials Services for Businesses
-
Insurance Technology Leader EIS Announces Growth Investment of More than $100 Million from TPG
-
Insurance Technology Leader EIS Announces Growth Investment of More than $100 Million from TPG
-
UPDATE: William Blair Starts Zymergen Inc (ZY) at Outperform
-
UPDATE: William Blair Starts Twist Bioscience (TWST) at Outperform
-
Thoma Bravo to take QAD Inc private for $2 billion
-
Duolingo Files Registration Statement for Proposed Initial Public Offering
-
Language App Duolingo (DUOL) Files $100M Nasdaq IPO, Discloses 97% Revenue Growth Rate in March Qtr
-
BTRS Holdings (BTRS) to Offer 9M Shares in Secondary Offering
-
BTRS Announces Launch of Public Offering of Common Stock
-
BTRS Announces Launch of Public Offering of Common Stock
-
Cadiz (CDZI) Announces Proposed Offering of 2M ADS
-
Cadiz Inc. Announces Offering of Depositary Shares and Series A Cumulative Perpetual Preferred Stock
-
Instructure Files Registration Statement with SEC for an Initial Public Offering
-
EQT Private Equity to acquire PRO Unlimited, a leader in contingent workforce management
-
UPDATE: William Blair Downgrades QAD Inc (QADA) to Market Perform
-
Sprinklr Announces Closing of Initial Public Offering
-
Alpha Teknova (TNKO) IPO Opens 29.5% Higher
-
Alpha Teknova, Inc. (TKNO) Prices 6M Share IPO at $16/sh
-
Teknova Announces Pricing of its Upsized Initial Public Offering
-
Teknova Announces Pricing of its Upsized Initial Public Offering
-
Doximity (DOCS) IPO Opens 58% Higher
-
OneSpaWorld Holdings Ltd. (OSW) Prices 8.4M Share Secondary Offering at $9.50/sh
-
OneSpaWorld Announces Pricing of Secondary Public Offering of Common Shares
-
Doximity (DOCS) IPO Prices at $26
-
Doximity Announces Pricing of Initial Public Offering
-
EagleTree Capital Acquires Integreon from NewQuest Capital Partners
-
Sachem Capital Corp. Prices Offering of Preferred Stock
-
Sprinklr (CXM) IPO Opens 9% Lower
-
Sachem Capital Corp. Announces Offering of Preferred Stock
-
Torrid Holdings Inc. Announces Launch of Initial Public Offering
-
OneSpaWorld Holdings Ltd. (OSW) Announces $80M Secondary Offering
-
OneSpaWorld Announces Proposed Secondary Public Offering of Common Shares
-
Sprinklr (CXM) Prices 16.6M Share IPO at $16/sh
-
Sprinklr Announces Pricing of Initial Public Offering
-
Talkspace Completes Merger with Hudson Executive Investment (HEC) and Will Begin Trading on Nasdaq Under the Symbol "TALK"
-
Talkspace, a Leading Virtual Behavioral Healthcare Company, Completes Merger with Hudson Executive Investment Corp. and Will Begin Trading on Nasdaq Under the Symbol "TALK"
-
Splunk (SPLK) Lands $1 Billion From Silver Lake, Announces Buyback One Day After Activist Rumors Surface
-
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

